Process and intermediates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10377697
APP PUB NO 20180354889A1
SERIAL NO

15780957

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS PHARMA AGLICHTSTRASSE 35 BASEL 4056

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allmendinger, Thomas Basel, CH 55 209
Filipponi, Paolo Basel, CH 3 13
Kleinbeck-Riniker, Florian Karl Basel, CH 6 2
Martin, Benjamin Basel, CH 35 273
Penn, Gerhard Basel, CH 13 17
Ruch, Thomas Basel, CH 36 243
Schlama, Thierry Basel, CH 15 37
Venturoni, Francesco Basel, CH 4 3
Wietfeld, Bernhard Basel, CH 23 149

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 13, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 13, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00